scorecardresearch
Follow Us:
Thursday, June 30, 2022

BDR Pharma launches generic cancer drug in India

Cabozantinib is used for the treatment of metastatic medullary thyroid cancer, advanced renal cell carcinoma and hepatocellular carcinoma, BDR Pharma said in a statement.

By: PTI | New Delhi |
Updated: September 14, 2021 7:30:57 pm
Cabozantinib is used for the treatment of metastatic medullary thyroid cancer, advanced renal cell carcinoma and hepatocellular carcinoma, BDR Pharma said in a statement | Representational image

Drug firm BDR Pharmaceuticals on Tuesday said it has launched generic Cabozantinib, used for the treatment of various types of cancer, and will bring the product in India in the next few days.

Cabozantinib is used for the treatment of metastatic medullary thyroid cancer, advanced renal cell carcinoma and hepatocellular carcinoma, BDR Pharma said in a statement.

“Ensuring that all our patients have access to quality-produced, world-class treatment at a reasonable rate was the main reason for launching the drug in India,” BDR Pharmaceuticals, Business Development – Director, Raheel Shah said.

The company, however, did not give any details about the cost of the drug.

Best of Express Premium
Efforts to estimate poverty from 2011-21 are commendable, given absence o...Premium
Uddhav Thackeray: The reluctant politician who in the end hung on to chai...Premium
Udaipur killers and Da’wat-e-Islami: the group, its ideology and its growthPremium
UPSC Key-June 29, 2022: Why to read ‘Dumping’ or ‘Gulabi Meenakari’ or ‘H...Premium

Cabozantinib is prescribed for treating patients with progressive, metastatic medullary thyroid cancer and as a second-line treatment for renal cell carcinoma apart from treating hepatocellular carcinoma, BDR Pharma said.

The drug is available in the strengths of 20 mg, 40 mg and 60 mg, it added.

Express Subscription Do not hit the wall. Get an Express subscription to access our award-winning journalism.

📣 Join our Telegram channel (The Indian Express) for the latest news and updates

For all the latest India News, download Indian Express App.

  • Newsguard
  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
  • Newsguard
0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.
Advertisement
Advertisement
Advertisement
Advertisement